| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 08/27/2008 | CN101249266A Nano liver target direction amphipathic nature block copolymers drug administration system and preparation |
| 08/27/2008 | CN101249263A Application of pig immune globulin for producing medicament for preventing and controlling dog infection of digestive canal disease |
| 08/27/2008 | CN101249260A Preparation of vaccines for preventing piglet diarrhoea |
| 08/27/2008 | CN101249251A Pharmaceutical combination for curing fatty liver and method of preparing the same |
| 08/27/2008 | CN101249248A Hepatitis B medicament and method of preparing the same |
| 08/27/2008 | CN101249245A Medicament for curing esophagus cancer and cardiac cancer |
| 08/27/2008 | CN101249242A Traditional Chinese medicine preparation for broad-spectrum curing gastropathy and method of preparing the same |
| 08/27/2008 | CN101249231A Medicine composition for treating lithiasis and preparation thereof |
| 08/27/2008 | CN101249217A Externally used mongolian medicine patch and preparing method for curing children's anorexia |
| 08/27/2008 | CN101249195A Medicament recuperating astriction and removing toxin stagnation and method of preparing the same |
| 08/27/2008 | CN101249192A Stomach healing capsules for curing gastropathy |
| 08/27/2008 | CN101249191A Traditional chinese medicine preparation for curing spew |
| 08/27/2008 | CN101249186A Chinese medicine oil solution curing trauma, rheumatalgia and dentalgia |
| 08/27/2008 | CN101249177A Applications of knotted flower phyla herb extract for hepatitis medicament |
| 08/27/2008 | CN101249176A Chinese medicine prescription for steaming and soaking foots |
| 08/27/2008 | CN101249171A Calculi discharging medicament |
| 08/27/2008 | CN101249165A Health-care medicinal wine for curing gastric ulcer |
| 08/27/2008 | CN101249149A Pharmaceutical combination for intestinal tract hemostasia and method of preparing the same |
| 08/27/2008 | CN101249144A Harbin pharmaceutical Anghema abdominal pain sticking |
| 08/27/2008 | CN101249143A Preparation for increasing medicinal value of Parasitism in Cistanche decoction pieces |
| 08/27/2008 | CN101249142A Medicament for gastrointestinal tract operation front intestinal tract cleaning |
| 08/27/2008 | CN101249139A Medicament for curing babies diarrhoea or autumn diarrhoea |
| 08/27/2008 | CN101249136A Applications of compound red sage root tablet for pharmacy |
| 08/27/2008 | CN101249132A Preparation technique of humifuse euphorbia effective ingredient |
| 08/27/2008 | CN101249131A Gynostemma pentaphylla soft capsules preparations and method of preparing the same |
| 08/27/2008 | CN101249126A Preparation technique of reducing fever powder capsule |
| 08/27/2008 | CN101249118A Chinese medicine extract and medicine use thereof |
| 08/27/2008 | CN101249117A Method for extracting flavonoid from Sarcopyramis nepalensis Wall |
| 08/27/2008 | CN101249109A Lactobacillus reuteri hollow micro-capsule and its preparing method |
| 08/27/2008 | CN101249097A Applications of ash tree flowers polysaccharide for preparing preventing and controlling pig virosis medicament |
| 08/27/2008 | CN101249096A Solid preparations containing diastatin Nystatin and menthol |
| 08/27/2008 | CN101249078A Sodium rebeprazole freeze-dried injection |
| 08/27/2008 | CN101249073A Pantoprazole sodium liposomes freeze-dry preparations and method of preparing the same |
| 08/27/2008 | CN100413970C Hepatitis B surface antigen blending gene and protein for carboxyl terminal containing precursor S2 immune decision cluster |
| 08/27/2008 | CN100413958C Bifidobacterium possessing characteristic for anti pathogenesis bacterium in intestinal tract and antioxidation, and application |
| 08/27/2008 | CN100413885C Modified proteins, designer toxins and methosd of making thereof |
| 08/27/2008 | CN100413883C Peptidic compounds selectively binding to p-selectin |
| 08/27/2008 | CN100413882C Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 08/27/2008 | CN100413881C Eplerenone crystalline form |
| 08/27/2008 | CN100413866C Riboflavin derivative and its preparation method and uses |
| 08/27/2008 | CN100413863C Novel 1,2,3-substituted indolizine derivatives, inhibitors of FGFs, method for making same and pharmaceutical compositions containing same |
| 08/27/2008 | CN100413850C Chemical compounds |
| 08/27/2008 | CN100413532C Medicine composition for anti consumptive disease |
| 08/27/2008 | CN100413526C Gastrointestinal health oral liquid and its preparing method |
| 08/27/2008 | CN100413512C Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass |
| 08/27/2008 | CN100413495C Medical use of 2 alpha, 3 beta-dihydroxy-5, 11(13)- diallyl eudesmane-12 acid for inhibiting hepatitis B virus |
| 08/26/2008 | US7417110 Biocompatability; polyphosphoester/polyphosphoramidate linkages; improved gene delivery into muscles; DNA vaccines |
| 08/26/2008 | US7417050 Cognition activators; Alzheimer's disease; attention deficit disorders; Parkinson's disease; Huntington's disease; neurodegenerative disease |
| 08/26/2008 | US7417049 Furyl compounds |
| 08/26/2008 | US7417038 administering to the patient an effective amount of an agent which reduces sympathetic nervous system activity; a beta receptor blocker or a compound which inhibits the effect of aldosterone |
| 08/26/2008 | US7417035 Phospholipid derivatives of non-steroidal anti-inflammatory drugs |
| 08/26/2008 | US7417034 Pharmaceutically active uridine esters |
| 08/26/2008 | US7417033 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells |
| 08/26/2008 | US7417029 Using an interleukin-1 beta converting enzyme inhibitor pro-drug to treat apoptosis-, interferon-gamma inducing factor or interferon-gamma inducing diseases; antiinflammatory and -proliferative agents; autoimmune/degenerative disesesdiseases |
| 08/26/2008 | US7417027 For decreasing food intake; eating disorders; sexual disorders |
| 08/26/2008 | US7416885 Proliferation factor is obtained from the UCHT1 rat thyroid cell line, or a fragment, analogue or derivateve |
| 08/26/2008 | US7416874 For use in food and feeds |
| 08/26/2008 | US7416858 Forming a convalent conjugate of a peptide, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety |
| 08/26/2008 | US7416730 Derivatives of the IL-2 receptor gamma chain, their production and use |
| 08/26/2008 | CA2432129C Pyrazole compounds useful as protein kinase inhibitors |
| 08/26/2008 | CA2360300C A transdermal composition of an antivomiting agent and a preparation containing the same |
| 08/26/2008 | CA2304977C Equine feed product containing lactobacillus |
| 08/26/2008 | CA2171550C Nucleosides with anti-hepatitis b virus activity |
| 08/26/2008 | CA2160779C Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient |
| 08/21/2008 | WO2008100547A2 Compositions comprising lamiridosin, iridoids or derivatives thereof for treatment of hepatitis c or hepatitis b |
| 08/21/2008 | WO2008100497A1 Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations |
| 08/21/2008 | WO2008100422A1 Compositions comprising mkc-733 (pumosetrag) useful for treating irritable bowel syndrome |
| 08/21/2008 | WO2008099912A1 5ht4 receptor antagonist |
| 08/21/2008 | WO2008099906A1 Therapeutic agent for periodontal disease and alveolar bone loss due to surgery |
| 08/21/2008 | WO2008099853A1 Medicinal composition for promoting periodontal tissue regeneration and agent for promoting periodontal tissue regeneration |
| 08/21/2008 | WO2008099829A1 Method for formation of intestinal adhesion in experimental animal, method for production of experimental animal having intestinal adhesion, method for screening of intestinal adhesion-preventing agent, and intestinal adhesion-preventing agent |
| 08/21/2008 | WO2008099615A1 Pharmaceutical composition containing fine particle oil-based suspension |
| 08/21/2008 | WO2008099544A1 Novel lactic acid bacteria |
| 08/21/2008 | WO2008099186A1 Heterocyclic derivatives as m3 muscarinic receptors |
| 08/21/2008 | WO2008099019A1 6-hydroxy-dibenzodiazepinones useful as hepatitis c virus inhibitors |
| 08/21/2008 | WO2008098503A1 Culture medium for bifidobacterium longum, composition comprising the same and preparation method thereof |
| 08/21/2008 | WO2008011016A3 Treating gastroesophageal reflux disease with 5-ht3- and gaba receptor agonists |
| 08/21/2008 | WO2008007063A3 Anti-obesity product and it's method of preparation |
| 08/21/2008 | US20080200517 Racemic 2[[(4-methoxy-3-methyl-2-pyridinyl)-methyl]sulfinyl]-5-(1H-pyrrol-1-yl)-1H-benzimidazole (ilaprazole) solvates having distinctive x-ray powder diffraction patterns and DSC thermograms; inhibiting gastric acid secretion; gastrointestinal inflammatory disorders; solubility, stability |
| 08/21/2008 | US20080200516 Solid state forms of racemic ilaprazole |
| 08/21/2008 | US20080200515 Solid state forms of enantiopure ilaprazole |
| 08/21/2008 | US20080200504 non-peptide NK-3 receptor ligands; anxiety, depression, schizophrenia, obesity; 2-Phenyl-quinoline-4-carboxylic acid (1-pyridin-4-yl-propyl) amide; reacting the 2-phenyl-quinolinyl-4-carbonyl chloride with a pyridylalkylamine to form the amide |
| 08/21/2008 | US20080200494 Imidazopyridine Derivatives |
| 08/21/2008 | US20080200471 central nervous system disorders; mood or cognitive disorder; gastrointestinal disorders; 4-methyl-7-[(6-piperazin-1-yl-1H-indol-1-yl)sulfonyl]-3,4-dihydro-2H-1,4-benzoxazine; 1-methyl-5-[(6-piperazin-1-yl-1H-indol-1-yl)sulfonyl]-1H-indole; 6-(6-Piperazin-1-yl-indole-1-sulfonyl)-4H-benzo[1,4]oxazin-3-one |
| 08/21/2008 | US20080200454 Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
| 08/21/2008 | US20080200420 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes |
| 08/21/2008 | US20080200407 Suppress the immunoreactivity of a CpG motif and preventing and treating immune-mediated diseases such as arthritis |
| 08/21/2008 | US20080200378 KGF polypeptide compositions |
| 08/21/2008 | US20080199470 Using serum granulin-epithelin precursor (GEP) concentrations as diagnostic indicator of hepatic tumor growth; immunodiagnostics; immunotherapy |
| 08/21/2008 | US20080199468 Method For Diagnosing Colorectal Cancers |
| 08/21/2008 | US20080199444 Administering Bacillus, Clostridium, or Bifidobacterium and oligosaccharide; Irritable bowel syndrome or diarrhea which starts after eating cold or raw food or drinking alcohol |
| 08/21/2008 | US20080199435 IL-8 Like Protein |
| 08/21/2008 | DE102007008664A1 Mittel zur Anwendung bei Fructoseintoleranz Means for use in fructose intolerance |
| 08/21/2008 | CA2677842A1 Pharmaceutical composition comprising microparticle oily suspension |
| 08/21/2008 | CA2677783A1 Compositions and methods for treatment of liver disease |
| 08/21/2008 | CA2677679A1 Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations |
| 08/21/2008 | CA2676581A1 Heterocyclic derivatives as m3 muscarinic receptors |
| 08/20/2008 | EP1958958A1 Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 08/20/2008 | EP1958956A2 Peptidomimetic protease inhibitors |
| 08/20/2008 | EP1957509A2 Methods and compositions for the treatment of gastrointestinal disorders |